These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2292010)

  • 41. Targeted cytotoxic cells as a novel form of cancer immunotherapy.
    Segal DM; Garrido MA; Perez P; Titus JA; Winkler DA; Ring DB; Kaubisch A; Wunderlich JR
    Mol Immunol; 1988 Nov; 25(11):1099-103. PubMed ID: 3265476
    [No Abstract]   [Full Text] [Related]  

  • 42. In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. II. Separation of natural killer cells and cytotoxic T cells.
    Le Gros GS; Herbert AG; Watson JD
    Immunology; 1984 Jan; 51(1):103-13. PubMed ID: 6606615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generation of natural killer-like cytotoxicity from human thymocytes with interleukin-2.
    Gray JD; Torten M; Golub SH
    Nat Immun Cell Growth Regul; 1983-1984; 3(3):124-33. PubMed ID: 6209571
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Lectin-dependent cytotoxicity of human peripheral blood lymphocytes].
    Bykovskaia SN; Blokhina NG; Vasil'eva ER; Agafonov VA; Raushenbakh MO
    Biull Eksp Biol Med; 1983 Mar; 95(3):48-51. PubMed ID: 6219723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Role of lymphokines in the generation of cytotoxic T lymphocytes].
    Kasakura S
    Rinsho Ketsueki; 1984 Apr; 25(4):479-87. PubMed ID: 6236311
    [No Abstract]   [Full Text] [Related]  

  • 46. [New insights into cytotoxic effector cells].
    Rey J; Olive D; Sébahoun G; O'Callaghan T; Costello RT
    Bull Cancer; 2005 Nov; 92(11):935-43. PubMed ID: 16316827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytotoxic lymphocytes in human intestinal mucosa.
    Shanahan F; Brogan M; Nayersina R; Targan S
    Adv Exp Med Biol; 1987; 216A():457-63. PubMed ID: 3500580
    [No Abstract]   [Full Text] [Related]  

  • 48. Lymphocyte-mediated cytotoxicity in vitro and in vivo: mechanisms and significance.
    Kägi D; Ledermann B; Bürki K; Zinkernagel RM; Hengartner H
    Immunol Rev; 1995 Aug; 146():95-115. PubMed ID: 7493763
    [No Abstract]   [Full Text] [Related]  

  • 49. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies concerning the relationship of Pichinde virus-induced natural killer cells and cytotoxic T lymphocytes.
    Rosenthal KL; Steiner C; Rawls WE; Walker CM
    Med Microbiol Immunol; 1986; 175(2-3):133-6. PubMed ID: 3487704
    [No Abstract]   [Full Text] [Related]  

  • 51. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
    Kumano M; Hara I; Furukawa J; Oniki S; Nagai H; Miyake H; Fujisawa M
    J Urol; 2007 Oct; 178(4 Pt 1):1504-9. PubMed ID: 17707061
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting and activation of cytotoxic lymphocytes.
    Segal DM; Snider DP
    Chem Immunol; 1989; 47():179-213. PubMed ID: 2692611
    [No Abstract]   [Full Text] [Related]  

  • 53. Targeting of cytotoxic cells with heterocrosslinked antibodies.
    Segal DM; Wunderlich JR
    Cancer Invest; 1988; 6(1):83-92. PubMed ID: 3284611
    [No Abstract]   [Full Text] [Related]  

  • 54. Natural and antibody-dependent killer cells in the thymus.
    Zöller M; Andrighetto G; Heyman B
    Eur J Immunol; 1982 Nov; 12(11):914-21. PubMed ID: 6185347
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effects of interferons on syngeneic murine malignant glioma-specific killer T cell].
    Yamasaki T; Yamashita J; Handa H; Namda Y; Hanaoka M
    No Shinkei Geka; 1983 Oct; 11(10):1059-67. PubMed ID: 6196674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of immunological parameters during tumour development in a murine model.
    Suresh K; Nirmala K; Kuruvilla K; Vasudevan DM
    Indian J Exp Biol; 1989 Jun; 27(6):497-501. PubMed ID: 2583740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer.
    Hall SJ; Sanford MA; Atkinson G; Chen SH
    Cancer Res; 1998 Aug; 58(15):3221-5. PubMed ID: 9699645
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice.
    Zhu XL; Chen AF; Lin ZB
    J Ethnopharmacol; 2007 May; 111(2):219-26. PubMed ID: 17182202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Localization of Fas ligand in cytoplasmic granules of CD8+ cytotoxic T lymphocytes and natural killer cells: participation of Fas ligand in granule exocytosis model of cytotoxicity.
    Kojima Y; Kawasaki-Koyanagi A; Sueyoshi N; Kanai A; Yagita H; Okumura K
    Biochem Biophys Res Commun; 2002 Aug; 296(2):328-36. PubMed ID: 12163021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anatomy of a murder: how cytotoxic T cells and NK cells are activated, develop, and eliminate their targets.
    Lieberman J
    Immunol Rev; 2010 May; 235(1):5-9. PubMed ID: 20536551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.